In a nutshell This study compared patients with therapy-resistant high blood pressure (HBP) and type 1 diabetes (T1D) to those who treated HBP to examine if these patients had more health complications. The results showed that patients with resistant HBP had a greater chance of having worse T1D complications, heart disease, and stroke than those...
Read MoreOther concurrent condition(s)-Hypertension Posts on Medivizor
Can diet control blood pressure in patients with diabetes?
In a nutshell This study reviewed dietary approaches to lower blood pressure in patients with type 2 diabetes (T2D). It found that several diets including low-sodium, high-fiber, DASH, low-protein, and vegan were effective in reducing blood pressure in patients with T2D. Some background Patients with T2D have higher average blood pressure and are at...
Read MoreEffect of alogliptin on blood pressure in hypertensive patients with type 2 diabetes
In a nutshell This article investigated the effect of alogliptin (Nesina) on blood pressure (BP) in patients with hypertension (HTN; high blood pressure) and type 2 diabetes (T2D). The authors concluded that alogliptin was associated with improved blood sugar control, BP and arterial stiffness in these patients. Some...
Read MoreCan high blood pressure lead to nerve disease in type 1 diabetes?
In a nutshell The aim of this study was to investigate if high blood pressure contributes to nerve disease (diabetic neuropathy; DN) in type 1 diabetes (T1D). The main finding of the study was that high blood pressure does contribute to impaired nerve conduction in T1D. Some background Diabetic nerve disease (DN) is a common complication of...
Read MoreEvaluating intensive blood pressure treatment for patients with diabetes
In a nutshell This study evaluated the optimal blood pressure (BP) control in patients with diabetes. This study concluded that intensive BP therapy was associated with a significantly lower risk for cardiovascular events. Some background Uncontrolled BP remains a leading cause of cardiovascular diseases and death in patients with diabetes. Ideal BP...
Read MoreEvaluating the effects of liraglutide on blood pressure and heart rate in patients with hypertension and T2D
In a nutshell This study determined the effects of liraglutide (Victoza) on blood pressure (BP) and heart rate in patients with hypertension (abnormally high blood pressure) and poorly controlled Type 2 diabetes (T2D). This study concluded that liraglutide improved systolic BP (SBP; the first number of the BP which refers to the pressure when the heart...
Read MoreWhat is the best target for blood pressure in people with type 2 diabetes?
In a nutshell This study investigated the ideal blood pressure target for people with type 2 diabetes (T2D). It was determined that a systolic blood pressure (SBP, pressure when the heart contracts) of 130-139 mmHg reduced complications of high blood pressure, but there was limited evidence that lowering of SBP below 130 mmHg had benefits, and that...
Read MoreDo blood sugar medications increase heart attack risk in patients with diabetes receiving dialysis for kidney disease?
In a nutshell This study investigated if medications used to treat high blood sugar increased the risk of heart attack in patients with diabetes and end-stage kidney disease undergoing dialysis. This study concluded that patients taking non-insulin drugs were more likely to have a heart attack. Some background Diabetes is an illness that...
Read MoreIs blood pressure adequately controlled in patients with type 2 diabetes?
In a nutshell This study examined whether blood pressure is adequately controlled in patients with type 2 diabetes who are at high risk of cardiovascular disease. The authors concluded that blood pressure is not sufficiently controlled in the majority of patients with type 2 diabetes. Some background Cardiovascular disease (CVD) is a common...
Read MoreA treatment for both blood pressure and blood glucose in type 2 diabetes
In a nutshell This study examined the safety and effectiveness of empagliflozin (Jardiance) in patients with type 2 diabetes and hypertension (high blood pressure). Some background Type 2 diabetes is associated with a 67–78% lifetime risk of cardiovascular disease. Hypertension (high blood pressure) affects roughly two thirds...
Read MoreEfficacy and Safety of Dapagliflozin (Forxiga) in Type 2 Diabetics Treated with High Doses of Insulin
In a nutshell This trial assessed the efficacy and safety of a new diabetes drug, Dapagliflozin (Forxiga). Results revealed that the drug helps control difficult cases of type 2 diabetes with only moderate side-effects. Some background Dapagliflozin is a drug recently approved by the European Medicines Agency for the treatment of diabetes. Its...
Read MoreManaging type 1 diabetes before and during pregnancy
Type 1 diabetes mellitus (T1DM) is associated with a higher risk of complications during pregnancy, both for the mother and the developing fetus. These can often be prevented with careful management. This article outlines current guidelines regarding T1DM management before and during pregnancy. Before pregnancy Pre-conception tests should...
Read More